≥98%HPLC Purity
COAIncluded
USAShipped
Argireline (Acetyl Hexapeptide-3) Peptide
Acetyl hexapeptide-3 targeting the SNARE complex (SNAP-25 analog). Researched for reducing neurotransmitter release at the neuromuscular junction in cosmetic dermal studies.
Coming Soon
This compound is currently in our development pipeline. Enter your email to be notified when it becomes available for research purchase.
Quick Facts
| SKU | ARG-001 |
|---|---|
| CAS Number | 616204-22-9 |
| Molecular Formula | C₃₄H₆₀N₁₄O₁₂S |
| Molecular Weight | 888.98 g/mol |
| Sequence | Ac-EEMQRR-NH₂ |
| Purity | ≥98% |
| Physical Form | Lyophilized Powder |
| Storage | Store at -20°C |
What is Argireline?
Argireline (Acetyl Hexapeptide-3) targets the SNARE complex by competing with SNAP-25. In clinical studies by Lipotec, a 10% Argireline solution reduced wrinkle depth by up to 30% after 30 days. It prevents synaptic vesicle docking without causing muscle atrophy.
Frequently Asked Questions
How effective is Argireline vs Botox?
Argireline reduces wrinkle depth by ~30% topically vs ~80% for injectable Botox. Argireline is non-invasive, reversible within hours, and acts at the SNARE level while Botox cleaves SNAP-25 irreversibly for 3-6 months.
For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.